- Home
- EEA vs ENZ Comparison
EEA vs ENZ Comparison
Compare EEA & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEA
- ENZ
- Stock Information
- Founded
- EEA 1986
- ENZ 1976
- Country
- EEA Germany
- ENZ United States
- Employees
- EEA N/A
- ENZ 136
- Industry
- EEA Trusts Except Educational Religious and Charitable
- ENZ Medical Specialities
- Sector
- EEA Finance
- ENZ Health Care
- Exchange
- EEA Nasdaq
- ENZ Nasdaq
- Market Cap
- EEA 60.8M
- ENZ 37.9M
- IPO Year
- EEA N/A
- ENZ N/A
- Fundamental
- Price
- EEA $8.58
- ENZ $0.71
- Analyst Decision
- EEA
- ENZ
- Analyst Count
- EEA 0
- ENZ 0
- Target Price
- EEA N/A
- ENZ N/A
- AVG Volume (30 Days)
- EEA 9.2K
- ENZ 198.0K
- Earning Date
- EEA 01-01-0001
- ENZ 12-16-2024
- Dividend Yield
- EEA 1.92%
- ENZ 14.27%
- EPS Growth
- EEA N/A
- ENZ N/A
- EPS
- EEA N/A
- ENZ N/A
- Revenue
- EEA N/A
- ENZ $30,314,000.00
- Revenue This Year
- EEA N/A
- ENZ N/A
- Revenue Next Year
- EEA N/A
- ENZ N/A
- P/E Ratio
- EEA N/A
- ENZ N/A
- Revenue Growth
- EEA N/A
- ENZ 2.72
- 52 Week Low
- EEA $7.45
- ENZ $0.68
- 52 Week High
- EEA $9.26
- ENZ $1.50
- Technical
- Relative Strength Index (RSI)
- EEA 42.05
- ENZ 16.88
- Support Level
- EEA $8.57
- ENZ $0.68
- Resistance Level
- EEA $8.69
- ENZ $1.05
- Average True Range (ATR)
- EEA 0.12
- ENZ 0.06
- MACD
- EEA 0.01
- ENZ -0.03
- Stochastic Oscillator
- EEA 28.89
- ENZ 7.00
About EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.